Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Setmelanotide

Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity

Rhythm · Phase 2 · Completed · Enrollment 213

NCT03013543

EudraCT 2017-000387-14

ArmPopulationDoseWeeksEstimandWeight change
16p11.2 CohortObesity or overweightn/r16n/rn/r
AS CohortObesity or overweightn/r16n/rn/r
BBS CohortObesity or overweightn/r16n/rn/r
MC4R CohortObesity or overweightn/r16n/rn/r
POMC/PCSK1/LEPR Heterozygous CohortObesity or overweightn/r16n/rn/r
POMC/PCSK1/LEPR Composite Heterozygous CohortObesity or overweightn/r16n/rn/r
POMC/PCSK1/LEPR Compound Heterozygous CohortObesity or overweightn/r16n/rn/r
SH2B1 CohortObesity or overweightn/r16n/rn/r
SMS CohortObesity or overweightn/r16n/rn/r
SRC1 CohortObesity or overweightn/r16n/rn/r